33 results on '"De Nicola S."'
Search Results
2. OC.16.6: APPLICATION OF MACHINE LEARNING MODEL-3P TO PREDICT PORTAL HYPERTENSION IN PATIENT WITH HEPATOCELLULAR CARCINOMA
3. T.07.4: ACTIVE HCV OR HBV INFECTION DOES NOT IMPACT ON CLINICAL OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
4. Myosteatosis is not associated with complications or survival in HCC patients undergoing transarterial embolization
5. High Incidence of sepsis caused by MDR bacteria in patients undergoing Percutaneous biliary drainage for the treatment of biliary obstruction
6. OC.12.5 MYOSTEATOSIS IS NOT ASSOCIATED WITH COMPLICATIONS OR SURVIVAL IN HCC PATIENTS UNDERGOING TRANS ARTERIAL EMBOLIZATION
7. Liver transplant recipients with Covid-19: results from an Italian multicenter cohort
8. Liver transplant candidates and SARS-CoV-2 infection: Results from an Italian multicenter cohort
9. COVID-19-related thrombotic microangiopathy in a cirrhotic patient
10. Early liver transplantation in active drinkers with and without alcoholic hepatitis: a monocentric case series
11. Transjugular intrahepatic portosystemic shunt is an effective and safe treatment of cirrhotic patients with portal vein thrombosis or cavernoma
12. HEV infection: an emerging disease. One year observation in a tertiary care center in Milan
13. Clinical presentation and etiological spectrum of idiopathic non-cirrhotic portal hypertension (INCPH): data from the Italian Registry
14. Risk and outcome of hepatitis B virus (HBV) reactivation during chronic hepatitis C treatment with direct-acting antivirals (DAAs) in patients with HCV-related advanced fibrosis: A single-center experience
15. Changes of indications for liver transplantation in the era of direct acting antiviral therapy in Europe
16. Transjugular intrahepatic portosystemic shunt is a safe and effective approach in cirrhotic patients with splanchnic vein thrombosis
17. TM6SF2 and MBOAT7 genotype to determine alcohol-related liver damage in patients with HCV chronic hepatitis
18. A multicentre prospective study response to treatment in genotype 3 and 1b infected patients with sickest liver cirrhosis: SVR 4 is not a reliable measure
19. ITPA deficiency does not predict anaemia during Ribavirin containing DAA all oral regimens for HCV
20. The role of serum alphafetoprotein determination in HCV-cirrhosis after antiviral treatment
21. Missense variant in interferon-λ4 gene identifies HCV-1 infected patients carrying the unfavorable IL28B (T) allele with improved viral kinetics
22. OC-21 The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent
23. OC-31 Low rates of SVR to peg-interferon plus ribavirin in HCV genotype 1 IL28B rs12979860 CC cirrhotic patients without rapid virological response
24. T-31 Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C
25. OC7 AN IL28B POLYMORPHISM PREDICTS PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 4
26. P.1.29: A SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON PREVENTS INSULIN RESISTANCE IN CHRONIC HEPATITIS C PATIENTS
27. T-36 Fibrosis progression in patients with chronic hepatitis C is not influenced by IL28B polymorphisms
28. T-42 A sustained virological response to interferon prevents insulin resistance in chronic hepatitis C patients
29. OC.03.3 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY
30. P.130 SAFETY AND EFFICACY OF PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND HIGH TITRES OF SERUM AUTOANTIBODIES: A SUB-ANALYSIS OF THE MIST STUDY
31. F.N.29 INSULIN RESISTANCE DOES NOT PREDICT A RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A SUB-ANALYSIS OF THE MIST STUDY
32. T.N.38 SAFETY AND EFFICACY OF PEG-IFN/RBV THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND HIGH TITRES OF SERUM AUTOANTIBODIES: A SUB-ANALYSIS OF THE MIST STUDY
33. Linkage between interferon-λ4 and IL28B polymorphisms in HCV-4 patients treated with pegylated interferon and ribavirin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.